Literature DB >> 10611150

Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori.

E M El-Omar1, K Oien, L S Murray, A El-Nujumi, A Wirz, D Gillen, C Williams, G Fullarton, K E McColl.   

Abstract

BACKGROUND & AIMS: Helicobacter pylori is believed to predispose to gastric cancer by inducing gastric atrophy and hypochlorhydria. First-degree relatives of patients with gastric cancer have an increased risk of developing gastric cancer. The aim of this study was to determine the prevalence of atrophy and hypochlorhydria and their association with H. pylori infection in first-degree relatives of patients with gastric cancer.
METHODS: H. pylori status, gastric secretory function, and gastric histology were studied in 100 first-degree relatives of patients with noncardia gastric cancer and compared with those of controls with no family history of this cancer.
RESULTS: Compared with healthy controls, relatives of patients with gastric cancer had a higher prevalence of hypochlorhydria (27% vs. 3%) but a similar prevalence of H. pylori infection (63% vs. 64%). Relatives of cancer patients also had a higher prevalence of atrophy (34%) than patients with nonulcer dyspepsia (5%) matched for H. pylori prevalence. Among the relatives of cancer patients, the prevalence of atrophy and hypochlorhydria was increased only in those with evidence of H. pylori infection, was greater in relatives of patients with familial cancer than in relatives of sporadic cancer index patients, and increased with age. Eradication of H. pylori infection produced resolution of the gastric inflammation in each subject and resolution of hypochlorhydria and atrophy in 50% of the subjects.
CONCLUSIONS: Relatives of patients with gastric cancer have an increased prevalence of precancerous gastric abnormalities, but this increase is confined to those with H. pylori infection. Consequently, prophylactic eradication of the infection should be offered to such subjects.

Entities:  

Mesh:

Year:  2000        PMID: 10611150     DOI: 10.1016/s0016-5085(00)70410-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  51 in total

1.  The importance of interleukin 1beta in Helicobacter pylori associated disease.

Authors:  E M El-Omar
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  New approaches to Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Gastroenterol Rep       Date:  2001-06

3.  High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA.

Authors:  Christie E Choi; Amnon Sonnenberg; Kevin Turner; Robert M Genta
Journal:  Dig Dis Sci       Date:  2015-02-28       Impact factor: 3.199

4.  Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR.

Authors:  Richard H Argent; Youli Zhang; John C Atherton
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Kosuke Sakitani; Hiroharu Yamashita; Shuntaro Yoshida; Keisuke Hata; Takamitsu Kanazawa; Naoto Fujiwara; Takanori Kanai; Naohisa Yahagi; Osamu Toyoshima
Journal:  United European Gastroenterol J       Date:  2016-06-22       Impact factor: 4.623

Review 6.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

7.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

8.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

9.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

Authors:  N Broutet; M Plebani; C Sakarovitch; P Sipponen; F Mégraud
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

Review 10.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.